• 教室紹介
  • 研究/教育概要
  • スケジュール
  • スタッフ
  • データセンター
  • 研究業績
  • リンク
  • Facebookページ 東北大学大学院 医学系研究科 医学統計学分野

研究業績

学会発表


    2015年


  • 2015/02/20-21「第6回日本臨床試験研究会学術集会総会」東京都
    有吉 恵介, 岩瀬哲, 坪井正博, 井上彰, 後藤悌, 木原康太, 宮路天平, 山口拓洋. 緩和ケア領域における研究者主導型臨床試験の安全性情報の管理. (ポスター発表)
  • 2015/02/20-21「第6回日本臨床試験研究会学術集会総会」東京都
    宮路天平, 川口崇, 岩瀬哲, 小田桐弘毅, 山本大悟, 後藤悌, 坪井正博, 坪田優, 有吉恵介, 木原康太,山口拓洋. ePROを運用するために必要なインフラ整備と留意点の検討. (ポスター発表)
  • 2015/12/06 ???
    Saiko Kurosawa, MD1*, Hiroki Yamaguchi2, Takuhiro Yamaguchi3*, Keiko Fukunaga2*, Shunsuke Yui2*, Heiwa Kanamori4, Kensuke Usuki5*, Nobuhiko Uoshima6*, Masamitsu Yanada7*, Katsuhiro Shono8*, Toshimitsu Ueki9*, Ishikazu Mizuno10*, Shingo Yano11, Jin Takeuchi12, Junya Kanda13, Hiroshi Okamura14*, Kinuko Tajima1*, Yoshihiro Inamoto1*, Koiti Inokuchi, MD, PhD2 and Takahiro Fukuda1*. Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile. Program: Oral and Poster Abstracts. Session: 732. Clinical Allogeneic Transplantation: Results: Poster I. Saturday, December 6, 2014, 5:30 PM-7:30 PM, North Building, Hall E (Moscone Center).
  • ▲先頭へ戻る▲

    2014年


  • 2014/11/22「日本薬史学会2014年会」福岡県博多
    宮路天平, 山口拓洋, 津谷喜一郎. Cannabinoid-based medicinesの歴史と本邦における規制について. (口頭発表)
  • 2014/7/26-27
    「The 22st International Congress on Nutrition and Integrative Medicine」Hokkaido,Japan
    Tempei Miyaji, Sho Hangai, Satoru Iwase, Takashi Kawaguchi, Keisuke Ariyoshi, Takuhiro Yamaguchi. Efficacy of Oral AHCC? Supplementation in Female Breast Cancer Patients undergoing Anthracycline and Taxane based Adjuvant chemotherapy Multi-institutional, Randomized, Double-blind, Placebo controlled, Phase-II Study: A Study Protocol and the Study Progress.(ポスター発表)
  • 2014/06/20「第19回日本緩和医療学会学術大会」兵庫県神戸
    岩瀬哲,川口崇,金井良晃,所昭宏,山田公人,松田能宣,大熊加恵,稲田修士,柏谷優子,畝崎榮,山口拓洋. がん患者の倦怠感と疼痛、QOLに関する観察研究.
  • 2014/05/30-06/03「2014 ASCO Annual meeting」Chicago, U.S.A.
    D.Yamamoto, S.Iwase, T.Yamaguchi, Y.Tsubota, T.Kawaguchi, H.Odagiri, K.Ariyoshi, K.Kitamura. Patient preference trial comparing capecitabine and S-1 in metastatic breast cancer patients.
  • 2014/03/07-09「第36回日本造血細胞移植学会総会」沖縄県沖縄市
    中根孝彦, 中前博久, 黒澤彩子, 岡村篤夫, 日高道弘, 山下卓也, 河野彰夫, 斉藤健, 青山泰孝, 畑中一生, 片山義雄, 薬師神公和, 松井利充, 高見昭良, 山口拓洋, 日野雅之, 福田隆浩. HLA一致血縁または7-8/8HLA一致非血縁ドナーからの同種造血幹細胞移植におけるMMFおよびカルシニューリン阻害剤を用いたGVHD予防の有用性:多施設共同第2相臨床試験
  • 2014/03/14-15「第5回日本臨床試験研究会学術集会総会」東京都
    有吉恵介、岩瀬哲、宮路天平、木原康太、田原由紀子、山口拓洋. 緩和ケア領域の臨床試験実施中に得られる臨床安全性情報の取扱いに関するポリシーおよび標準業務手順書の確率に関する研究. (ポスター発表)
  • 2014/03/14-15「第5回日本臨床試験研究会学術集会総会」東京都
    宮路天平、岩瀬哲、有吉恵介、木原康太、田原由紀子、山口拓洋. オンライン医療情報の品質や信頼性の担保に関する研究. (ポスター発表)
  • ▲先頭へ戻る▲

    2013年


  • 2013/12/09 ???
    Clinical Allogeneic Transplantation - Acute and Chronic GVHD, Immune Reconstitution: Poster III. Result Type: Session. Program: Oral and Poster Abstracts. Time and Location:Monday, December 9, 2013: 6:00 PM-8:00 PM, Hall G (Ernest N. Morial Convention Center). Search Result:...PhD7*, Kazuo Hatanaka, MD8*, Yoshio Katayama, MD, PhD9, Kimikazu Yakushijin, MD, PhD3*, Toshimitsu Matsui, MD, PhD9, Akiyoshi Takami, MD, PhD10, Takuhiro Yamaguchi, PhD11*, Masayuki Hino, MD, PhD12 and Takahiro Fukuda, MD2*1Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan2Stem Cell...
  • 2013/12/10 ???
    Clinical Allogeneic and Autologous Transplantation - Late Complications and Approaches to Disease Recurrence: Late Complications. Result Type: Session. Program: Oral and Poster Abstracts. Time and Location:Tuesday, December 10, 2013:7:30AM-9:00AM, Riverside Rooms - R06-R07 (Ernest N. Morial Convention Center). Search Result:...MD, PhD6, Tetsuya Eto, MD, PhD7*, Hirohisa Nakamae, MD, PhD8*, Hisashi Sakamaki, MD, PhD9, Yasuo Morishima, MD10*, Ritsuro Suzuki, MD11, Takuhiro Yamaguchi, Ph.D.12* and Takahiro Fukuda, MD13*1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan2Department...
  • 2013/12/10 ???
    Cytomegalovirus Reactivation After Allogeneic Stem Cell Transplantation Is Associated With a Reduced Risk Of Relapse In Patients With Acute Myeloid Leukemia: The Japan Society For Hematopoietic Cell Transplantation (JSHCT) Transplantation-Related Complication Working Group. Result Type: Paper. Number: 915. Presenter: Katsuto Takenaka. Program: Oral and Poster Abstracts. Session: 723. Clinical Allogeneic and Autologous Transplantation - Late Complications and Approaches to Disease Recurrence: Late Complications. Time and Location: Tuesday, December 10, 2013: 7:30 AM-9:00 AM. Riverside Rooms - R06-R07 (Ernest N. Morial Convention Center). Search Result:...MD, PhD6, Tetsuya Eto, MD, PhD7*, Hirohisa Nakamae, MD, PhD8*, Hisashi Sakamaki, MD, PhD9, Yasuo Morishima, MD10*, Ritsuro Suzuki, MD11, Takuhiro Yamaguchi, Ph.D.12* and Takahiro Fukuda, MD13*1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan2Department...
  • 2013/12/09 ???
    Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7?8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial. Program: Oral and Poster Abstracts. Session: 722. Clinical Allogeneic Transplantation - Acute and Chronic GVHD, Immune Reconstitution: Poster III. Time and Location: Monday, December 9, 2013, 6:00 PM-8:00 PM. Hall G (Ernest N. Morial Convention Center). Search Result:...Takahiko Nakane, M.D., Ph.D.1*, Hirohisa Nakamae, MD, PhD1*, Saiko Kurosawa, MD2*, Atsuo Okamura, MD, PhD3*, Michihiro Hidaka, MD, PhD4*, Takuya Yamashita, MD, PhD2, Akio Kohno, MD, PhD5*, Takeshi Saito, MD6, Yasutaka Aoyama, MD, PhD7*, Kazuo Hatanaka, MD8*, Yoshio Katayama, MD, PhD9, Kimikazu Yakushijin, MD, PhD3*, Toshimitsu Matsui, MD, PhD9, Akiyoshi Takami, MD, PhD10, Takuhiro Yamaguchi, PhD11*, Masayuki Hino, MD, PhD12 and Takahiro Fukuda, MD2*...
  • 2013/12「第27回日本エイズ学会学術集会・総会」熊本
    関根祐介、東加奈子、添田博、川口崇、中原紀子、山口拓洋、竹内裕紀、畝崎榮、天野景裕、福武勝幸、明石貴雄. 「ART開始患者の葛藤に対する服薬説明の有用性~意思決定の葛藤尺度(Decisional Con?ict Scale)日本語版」を用いた解析~.
  • 2013/10/11-13「第75回血液学会学術集会」北海道札幌
    Voriconazole vs. itraconazole for antifungal prophylaxis in patients with GVHD: A randomized trial.(演題番号:OS-3-92) 林良樹(Yoshiki Hayashi):1,2, 神田善伸(Yoshinobu Kanda):3, 中前博久(Hirohisa Nakamae):1, 金森平和(Heiwa Kanamori):4, 大橋一輝(Kazuteru Ohashi):5, 日高道弘(Michihiro Hidaka):6, 矢野真吾(Shingo Yano):7, 畑中一生(Kazuo Hatanaka):8, 河野彰夫(Akio Kohno):9, 森内幸美(Yukiyoshi Moriuchi):10, 吾郷浩厚(Hiroatsu Ago):11, 山下卓也(Takuya Yamashita):2, 日野雅之(Masayuki Hino):1, 山口 拓洋(Takuhiro Yamaguchi):12, 福田隆浩(Takahiro Fukuda):2.
  • 2013/10/11‐13 「第75回日本血液学会学術集会」 北海道札幌
    uRIST with low-dose ATG-F-multicenter phase II trial-.(演題番号:OS-3-4) 藤重夫(Shigeo Fuji):1、金成元(Sung-Won Kim):1、矢野真吾(Shingo Yano):2、萩原將太郎(Shotaro Hagiwara):3、中前博久(Hirohisa Nakamae):4、日高道弘(Michihiro Hidaka):5、伊藤俊朗(Toshiro Ito):6、大橋一輝(Kazuteru Ohashi):7、畑中一生(Kazuo Hatanaka):8、高見昭良(Akiyoshi Takami):9、黒澤彩子(Saiko Kurosawa):1、山下卓也(Takuya Yamashita):1、山口拓洋(Takuhiro Yamaguchi):10、福田隆浩(Takahiro Fukuda):1
  • 2013/10/24‐26「第51回日本癌治療学会学術集会」京都府京都
    高津優人, 橋本浩伸, 矢内貴子, 久保晶子, 岩佐悟, 本間義崇, 高島淳生, 加藤健, 濱口哲弥, 山田康秀, 林憲一, 安西奈津美, 川口崇, 山口拓洋, 島田安博. 患者自己評価式有害事象評価(PRO-CTCAE)日本語版の予備的調査.
  • 2013/09/27-10/01「The European Cancer Congress 2013」Amsterdam, Netherlands
    H. Ishiki, S. Iwase, Y. Gyoda, Y. Kanai, K. Ariyoshi, T. Miyaji, Y. Tahara, T. Kawaguchi, T. Yamaguchi. Oral nutritional support can shorten the duration of parenteral hydration in end-of-life cancer patients: A randomized exploratory trial.
  • 2013/06/21-22「第18回日本緩和医療学会学術大会」神奈川県横浜
    石木寛人、岩瀬哲、行田泰明、金井良晃、有吉恵介、宮路天平、田原由紀子、川口崇、山口拓洋. 終末期がん患者に対するアミノ酸ゼリーの有用性を調べる前向き探索試験.
  • 2013/04/07-10「EBMT2013」London, UK
    The Impact of lung chronic GVHD on survival after cord blood transplantation. Seiko Kato*, Takuhiro Yamaguchi, Jun Ooi, Toshiro Kawakita, Masao Tsukada, Yasuhiro Ebihara, Shinji Mochizuki, Shouhei Yamamoto, Kohichiro Tsuji, Shigetaka Asano, Arinobu Tojo, Satoshi Takahashi (Tokyo, Sendai, JP)
  • ▲先頭へ戻る▲

    2012年


  • 2012/10/27-28「第22回日本医療薬学会年会」新潟県新潟
    東加奈子、川口崇、鮎原秀明、江田理子、大西正美、山口拓洋、濃沼政美、竹内裕紀、畝崎榮、明石貴雄. 抗がん剤治療を受けるがん患者が抱える葛藤に薬剤師の服薬説明が与える影響.
  • 2012/10/27-28「第22回日本医療薬学会年会」新潟県新潟
    佐野陽子、添田博、濵田泰子、東加奈子、川口崇、山口拓洋、恩田健二、エリックスカイヤー、竹内 裕紀、畝崎 榮、明石 貴雄. 『意思決定の葛藤尺度(DCS)』日本語版作成とその信頼性および妥当性の検討.
  • 2012/10/19-21「第73回日本血液学会総会」京都府京都
    柳田正光, 黒澤彩子,山口拓洋,内田直之,宮脇修一,金森平和,臼杵憲祐,小林武,渡辺正人,恵美宣彦,三浦偉久男, 福田隆浩. Effect of related donoravailability on outcome of AML in the context of related and unrelated HCT.
  • 2012/07/21「International Congress on Nutrition and integrative Medicine 2012」北海道札幌
    T. Miyaji, S. Hangai, S. Iwase, T. Kawaguchi, Y. Kogure, T. Yamaguchi. Exploratory Clinical Research on Active Hexose Correlated Compound in the Adjuvant Chemotherapy of Breast Cancer.
  • 2012/7/26「第10回日本臨床腫瘍学会学術集会」大阪府大阪
    山口拓洋他.PRO-CTCAE日本語版の開発計画と進捗状況.
  • 2012/04/01-04「EBMT2012」Geneva, Switzerland The impact of grade II acute GvHD on relapse and survival after cord blood transplantation. Toshiro Kawakita, Takuhiro Yamaguchi, Jun Ooi, Seiko Kato, Yasuhiro Ebihara, Shinji Mochizuki, Shohei Yamamoto, Kohichiro Tsuji, Shigetaka Asano, Arinobu Tojo, Satoshi Takahashi (Tokyo, Sendai, JP) .
  • ▲先頭へ戻る▲

    2011年


  • 2011/12/12 ???
    Matched HLA Haplotype Contributes to Reduce Sever Acute GVHD with Conserving GVL Effect in HLA-Mismatched Cord Blood Transplantation. Program: Oral and Poster Abstracts. Type: Poster. Session: 731. Clinical Allogeneic and Autologous Transplantation - Results: Poster III. Time and Location: Monday, December 12, 2011, 6:00 PM-8:00 PM. Hall GH (San Diego Convention Center). Search Result:...Satoshi Takahashi, M.D., Ph.D.1, Jun Ooi, MD2, Seiko Kato, M.D.2*, Toshiro Kawakita, M.D.2*, Arinobu Tojo, MD, PhD3, Yasuhiro Ebihara, MD, PhD4, Shinji Mochizuki, MD, PhD4*, Shohei Yamamoto, MD, PhD4*, Kohichiro Tsuji, MD, PhD4, Takuhiro Yamaguchi, Ph.D.5*, Satoko Morishima, MD., Ph.D.6*, Yasuo Morishima, MD, PhD7 and Shigetaka Asano, MD8...
  • 2011/03/09-10「第33回日本造血細胞移植学会総会」愛媛県松山
    柳田正光,黒澤彩子,山口拓洋,山下卓也,森内幸美,吾郷浩厚,竹内仁,中前博久,田口潤,佐倉徹,高松泰,脇房子,横山洋紀,渡辺正人,恵美宣彦,福田隆浩. Monosomal karyotypeを有する第1寛解期急性骨髄性白血病の予後. 
  • 2011/03/09-10「第33回日本造血細胞移植学会総会」愛媛県松山
    Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantaiton:results of younger patients. Yakushijin Kimikazu; 黒澤彩子; 山口拓洋; 熱田由子; 長村登紀子; 秋山秀樹; 谷口修一; 宮村耕一; 高橋聡; 衛藤徹也; 森島泰雄; 坂巻壽; 福田隆浩.
  • 2011/03/09-10 「第33回日本造血細胞移植学会総会」 愛媛県松山 Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantaiton:results of elderly patients. 黒澤彩子; Yakushijin Kimikazu; 山口拓洋; 熱田由子; 長村登紀子; 秋山秀樹; 谷口修一; 宮村耕一; 高橋聡; 衛藤徹也; 森島泰雄; 坂巻壽; 福田 隆浩.
  • ▲先頭へ戻る▲

    2010年


  • 有吉恵介,岩瀬哲,宮路天平,木原康太,田原由紀子,山口拓洋.緩和ケア領域の臨床試験実施中に得られる臨床安全性情報の取扱いに関するポリシー及び標準業務手順書の確立に関する研究.日本臨床試験研究会第5回学術集会総会.
  • 米田茂広,浅田隆太,清水忍,山口拓洋.本邦の新医薬品の審査機関を長くしている要因は何か.日本臨床試験研究会第5回学術集会総会.
  • Saiko Kurosawa, Kimikazu Yakushijin, Takuhiro Yamaguchi, Yoshiko Atsuta, Tokiko Nagamura-Inoue, Hideki Akiyama, Shuichi Taniguchi, Koichi Miyamura, Satoshi Takahashi, Tetsuya Eto, Yasuo Morishima, Hisashi Sakamaki, and Takahiro Fukuda. Changes In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving? Blood (ASH Annual Meeting Abstracts), Nov 2010; 116: 901.
  • ▲先頭へ戻る▲

    2009年


  • Satoshi Takahashi, Jun Ooi, Nobuhiro Tsukada, Seiko Kato, Aki Sato, Toshiro Kawakita, Yasuyuki Nagata, Maki Monna-Ooiwa, Arinobu Tojo, Takuhiro Yamaguchi, Satoko Morishima, Yasuo Morishima, and Shigetaka Asano. The Impact of HLA Haplotype Matching for Mismatched Cord Blood Transplantation. Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 1206.
  • Saiko Kurosawa, Takuhiro Yamaguchi, Naoyuki Uchida, Toru Sakura, Kensuke Usuki, Masato Watanabe, Takuya Yamashita, Heiwa Kanamori, Junji Tomiyama, Yuichiro Nawa, Shingo Yano, Jin Takeuchi, Kazuaki Yakushiji, Fumiaki Sano, Nobuhiko Uoshima, Yasuhito Nannya, Yoshiyuki Moriuchi, Yoichi Takaue, and Takahiro Fukuda. Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients. Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 524.
  • Saiko Kurosawa, Takuhiro Yamaguchi, Naoyuki Uchida, Shuichi Miyawaki, Heiwa Kanamori, Kensuke Usuki, Takuya Yamashita, Masato Watanabe, Kazuaki Yakushiji, Shingo Yano, Yuichiro Nawa, Jun Taguchi, Jin Takeuchi, Yuko Nakamura, Yasuhito Nannya, Yasushi Okoshi, Yoshinobu Kanda, Ikuo Miura, Yoichi Takaue, and Takahiro Fukuda. A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?. Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 2281.
  • ▲先頭へ戻る▲

    2008年


  • Satoshi Takahashi, Takuhiro Yamaguchi, Maki Monna-Ooiwa, Shuichi Taniguchi, Hisashi Sakamaki, Takeshi Morii, Yoshihisa Nagatoshi, Nobuyuki Aotsuka, Shunichi Kato, Minoko Takanashi, Tokiko Nagamura, Hiroshi Azuma, Shunro Kai, Koji Kato, and Shigetaka Asano. Contribution of HLA Incompatibility on Clinical Outcomes of CBT in Patients with MDS Including Secondary AML in Japan: Multivariate Analysis Using Competing Risk Regression Model. Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3004.
  • Atsushi Wakita, Shigeki Ohtake, Satoru Takada, Fumiharu Yagasaki, Hirokazu Komatsu, Yasushi Miyazaki, Koumei Kubo, Yukihiko Kimura, Akihiro Takeshita, Yoko Adachi, Hitoshi Kiyoi, Takuhiro Yamaguchi, Minoru Yoshida, Kazunori Ohnishi, Shuichi Miyawaki, Tomoki Naoe, Ryuzo Ueda, and Ryuzo Ohno. A Randomized Trial Comparing Individualized Vs. Non-Individualized Treatment for Elderly Acute Myeloid Leukemia: JALSG GML200 Study. Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 2961.
  • Takahashi S, Yamaguchi T, Monna-Ooiwa M, Taniguchi S, Akiyama H, Morii T, Nagari Y, Takaue Y, Okamoto S, Miyamura K, Sao H, Nagamura T, Kato S, Kawase T, Morishima Y, Asano S on behalf of the Japan Marrow Donor Program and the Japan Cord Blood Bank. Equivalent disease-free survival results after CBT and BMT from unrelated donor using TBI containing myeloablative regimen and calsinulin inhibitors plus MTX methods in patients with MDS in Japan: multivariate analysis by competing risk regression models. Bone Marrow Transplantation 2008; 41(Supplement 1s): S75.
  • ▲先頭へ戻る▲

    2007年


  • Miyakoshi S, Yamaguchi T, Kami M, Matsumura T, Yuji K, Narimatsu H, Kusumi E, Sakamaki H, Kouzai H, Okada M, Osugi Y, Kobayashi R, Inoue M, Takahashi S, Murata M, Kai S, Kato K, Nagamura T, Taniguchi S, Kato S. Acute Graft-Versus-Host Disease Following Umbilical Cord Blood Transplantation: Retrospective Survey Involving 2015 Japanese Patients. Blood (ASH Annual Meeting Abstracts), Nov 2007; 110: 1070.
  • Takita M, Yuji K, Yamaguchi T, Matsumura T, Kami M, Sakamaki H, Kouzai Y, Okada M, Osugi Y, Kobayashi R, Inoue M, Takahashi S, Murata M, Kai S, Kato K, Nagamura T, Taniguchi S, Kato S. Unrelated Cord Blood Transplanation for Malignant Lymphoma: A Retrospective Study from the Japan Cord Blood Bank Network (JCBNW). Blood (ASH Annual Meeting Abstracts), Nov 2007; 110: 2026.
  • Konuma T, Takahashi S, Ooi J, Tomonari A, Tsukada N, Kato A, Oiwa-Monna M, Uchimaru K, Tojo A, Yamaguchi T, Asano S. Unrelated Cord Blood Transplantation Using Myeloablative Regimen for Acute Leukemia Patients Aged between 50 and 55 Years: Single Institutional Retrospective Comparison with Patients Less Than 50 Years of Age. Blood (ASH Annual Meeting Abstracts), Nov 2007; 110: 2013.
  • Takahashi S, Yamaguchi T, Ooi J, Tomonari A, Tsukada N, Konuma T, Nagamura T, Kato S, Kawase T, Morishima Y, Asano S. The Comparative Analysis of Bone Marrow Transplantation and Cord Blood Transplantation from Unrelated Donors in Patients with Myelodysplastic Syndrome in Japan. Blood (ASH Annual Meeting Abstracts), Nov 2007; 110: 2012.
  • Kurokawa Y, Yamaguchi T, Yoshimura K, Yamamoto S, Nakamura N, Sasako M, Fukuda H. Quantitative evaluation of heterogeneities in treatment effects and baseline risks among hospitals: from a phase III surgical trial of gastric cancer. 43rd ASCO 2007 Annual Meeting; June 1-5, 2007.
  • Yamaguchi T, Mashiko K, Sakamoto Y, Kami M, Kusumi E, Ohara M, Hemmi H, Nishikawa W, Shinoda N, Kunimatsu T. Comparison between helicopter emergency medical services and ambulance transportation to rescue people injured by traffic crashes in Japan. 15th World Congress on Disaster and Emergency Medicine. Amsterdam, Netherlands, May, 2007. Prehospital and Disaster Medicine 2007; 22(2): s31.
  • ▲先頭へ戻る▲

    2006年


  • Yamaguchi T, Ohbu S, Saito M, Tashiro K, Moriwaka F, Ohashi Y, Suzukamo Y, Fukuhara S, Narita Y, Kuzuhara S. ALS Patient CARE Database in Japan -. 17th International Symposium on ALS/MND. Yokohama, Japan, Nov 30 - Dec 2, 2006.
  • ▲先頭へ戻る▲

    2004年


  • Yamaguchi T, Sylvester R, Oosterlinck W. Modeling of hazard function for recurrence of a single superficial bladder cancer: EORTC GU group trial 30863. The abstract of 25th annual conference of the International Society for Clinical Biostatistics. Leiden, Netherlands, August 15-19, 2004.
  • ▲先頭へ戻る▲

    2003年


  • Wang L, Yamaguchi T, Ohashi Y. Relationship between Development of Type 2 Diabetes and Physical Activity. Canada Diabetes Association 2003.
  • Matsuyama Y, Yamaguchi T. Analysis of time to event data with dependent competing risks: estimation of the marginal survival time using inverse probability of censoring weighted (IPCW) methods. Third joint meeting of the society for clinical trials and the international society of for clinical biostatistics. Controlled Clinical Trials 2003; 3S: 56S.
  • ▲先頭へ戻る▲

    2002年


  • 山口拓洋,橋本修二,岡 慎一,吉崎和幸,木村 哲,福武勝幸,白阪琢磨.血液製剤によるHIV感染者の調査成績 第2報 HIV薬の併用区分・併用薬剤の変更状況と変更前後での臨床状況の変化.日本エイズ学会誌,2002; 4: 403.
  • 山口拓洋,大橋靖雄.切除不応非小細胞肺がん臨床試験における後治療の影響を調整した群間比較.2002年度統計関連学会連合大会.
  • ▲先頭へ戻る▲

    2001年


  • 山口拓洋,橋本修二,岡 慎一,吉崎和幸,木村 哲,福武勝幸,白阪琢磨.血液製剤によるHIV感染者の調査成績 第2報 身体状況・日常生活動作の現状と推移.日本エイズ学会誌,2001; 3: 413.
  • 山口拓洋,大橋靖雄.慢性心不全患者を対象としたUD-CG115BSカプセル(ピモベンダン)の長期投与試験における、治療変更情報を利用した治療効果の推定.薬剤疫学,2001; 6S: S32-33.
  • Yamaguchi T, Hashimoto S, Oka S, Yoshizaki K, Kimura S, Fukutake K, Shirasaka T. Trends in CD4 Cell Counts, Plasma HIV-RNA Levels and the Use of Antiretroviral Therapy among Patients with HIV Infection through Blood Products. The 3rd Asian-Pacific Congress of Epidemiology, 2001-IEA Regional Scientific Meeting in Japan-.
  • ▲先頭へ戻る▲

    2000年


  • 山口拓洋,橋本修二,岡 慎一,吉崎和幸,木村 哲,福武勝幸,白阪琢磨.血液製剤によるHIV感染者の調査成績 第二報 CD4値、HIV-RNA量と抗HIV治療の推移、および、それらの関連.日本エイズ学会誌,2000; 2: 385.
  • ▲先頭へ戻る▲

    1996年


  • 山口拓洋,大橋靖雄.施設間差を考慮した生存時間解析.応用統計学会・日本計量生物学会1996年度合同年次大会講演要旨集,1996: 83 85.

▲先頭へ戻る▲

研究業績目次へ戻る


「リンク」ページはこちら